By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Cortice Biosciences 

50 W 57th Street, 15th Floor

New York  New York  10019  U.S.A.
Phone: 646-747-9090 Fax: n/a


SEARCH JOBS


Industry
Biotechnology






Company News
ASCO2016: Cortice Biosciences Announces Presentation Of Results From A Phase I/II Clinical Trial Evaluating TPI 287 For Treatment Of Recurrent Glioblastoma At The Annual Meeting Of The ASCO 6/3/2016 10:23:42 AM
Cortice Biosciences Announces Updated Results From Clinical Trials Evaluating TPI 287 For Treatment Of Brain Malignancies 11/20/2015 10:44:05 AM
Cortice Biosciences Announces Upcoming Presentations At The 20th Annual Society For Neuro-Oncology Annual Scientific Meeting And Education Day 11/9/2015 1:17:45 PM
Cortice Biosciences Announces Issuance Of A Key Patent Covering The Company's Alzheimer's Disease Drug Development Program 7/8/2015 10:34:29 AM
Cortice Biosciences To Present At Upcoming Conferences 5/26/2015 11:21:30 AM
Cortice Biosciences Announces Updated Results From A Phase 1/2 Clinical Trial Evaluating TPI 287 For Treatment Of Recurrent Glioblastoma 4/21/2015 8:01:26 AM
Cortice Biosciences Announces Upcoming Clinical Trial Presentation At The 15th Annual Meeting Of The American Association for Cancer Research 4/9/2015 9:38:24 AM
Cortice Biosciences Announces Enrollment Of A Phase 1 Trial Evaluating TPI 287 Plus Radiotherapy For Treatment Of Lung And Breast Cancer Metastases To The Brain 1/7/2015 9:49:40 AM
Cortice Biosciences Announces Initial Results From A Phase 1/2 Clinical Trial Evaluating TPI 287 For Treatment Of Recurrent Glioblastoma 11/14/2014 7:20:19 AM
Cortice Biosciences Announces Results From Studies Evaluating Pipeline Candidates TPI 287 And CRT 001 In Preclinical Models Of Tauopathies And Alzheimer's Disease 11/12/2014 7:31:05 AM
12
//-->